UK markets closed
NIKKEI 225
38,385.73 +29.67 (+0.08%) HANG SENG
19,073.71 -41.35 (-0.22%) CRUDE OIL
78.86 +0.84 (+1.08%) GOLD FUTURES
2,392.80 +32.90 (+1.39%) DOW
39,901.53 +343.42 (+0.87%) Bitcoin GBP
52,030.68 +3,514.70 (+7.24%)
BeiGene, Ltd. (6160.HK)
HKSE - HKSE Delayed price. Currency in HKD
Add to watchlist
At close: 04:08PM HKT
| Previous close | 96.950 |
| Open | 97.950 |
| Bid | 98.550 x 0 |
| Ask | 98.850 x 0 |
| Day's range | 97.450 - 99.900 |
| 52-week range | 75.450 - 146.500 |
| Volume | |
| Avg. volume | 1,399,616 |
| Market cap | 139.48B |
| Beta (5Y monthly) | 0.63 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -4.540 |
| Earnings date | 31 Jul 2024 - 07 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 170.47 |
Business WireBeiGene Highlights New Hematology Portfolio and Pipeline Data at EHA2024
SAN MATEO, Calif., May 14, 2024--BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced it will share new data from its hematology portfolio and pipeline at the European Hematology Association 2024 Hybrid Congress (EHA2024) in Madrid, Spain, June 13-16, 2024. BeiGene has 28 abstracts accepted at EHA2024, with four scheduled for oral presentations.
Simply Wall St.The BeiGene, Ltd. (NASDAQ:BGNE) First-Quarter Results Are Out And Analysts Have Published New Forecasts
A week ago, BeiGene, Ltd. ( NASDAQ:BGNE ) came out with a strong set of quarterly numbers that could potentially lead...
Simply Wall St.BeiGene First Quarter 2024 Earnings: Beats Expectations
BeiGene ( NASDAQ:BGNE ) First Quarter 2024 Results Key Financial Results Revenue: US$751.7m (up 68% from 1Q 2023). Net...
© 2024 Yahoo. All rights reserved.